Possible role of P-glycoprotein in cyclophosphamide resistance of transplanted mouse RLS lymphosarcoma
Possible role of P-glycoprotein in cyclophosphamide resistance of transplanted mouse RLS lymphosarcoma
复制标题
DOI:
10.1007/s10517-005-0358-3
复制
发表时间:
2005-05-01
影响因子:
0.7
通讯作者:
Lyakhovich, VV
中科院分区:
文献类型:
--
作者:
Grishanova, AY;Mel'nikova, EV;Lyakhovich, VV
The causes of different sensitivity of mouse LS lymphosarcoma and its resistant RLS variant to cyclophosphamide were studied. Division of LS and RLS cells stops in the G(2)/M phase 24 h after cyclophosphamide treatment, but this stop lasts for more than 48 h in LS cells and less than 24 h in RLS cells. DNA fragmentation, a marker of apoptosis, is observed only in LS cells starting from 24 h after cyclophosphamide treatment. LS and RLS strains do not differ by the expression of bcl-2, bcl-6, bax, bad, mdr1a, mdr1b genes and P-glycoprotein protein. The strains differ by transport activity of P-glycoprotein, tested by SYTO 16 substrate release from cells: activity of P-glycoprotein in RLS cells was 2-fold higher than in LS cells. Presumably, the resistance of RLS tumor to cyclophosphamide-induced apoptosis is a result of inhibition of the apoptotic cascade by P-glycoprotein which is functionally more active in these cells than in LS cells.